An open-label phase 2 clinical trial of topical remetinostat gel for basal cell carcinoma Urman, N., Eichstadt, S., Do, H., Mirza, A. N., Li, S., Oro, A., Aasi, S., Sarin, K. Y. ELSEVIER SCIENCE INC. 2019: S171

View details for Web of Science ID 000465561505130